mTOR Signaling in Inflammation, Brain Injuries and Neurodegeneration

Dear Colleagues,

Neurodegeneration is characterized by overlapping impairment in processes including protein synthesis and degradation, protein misfolding and aggregation, activation of neuron cell death mechanisms, inflammation, gliosis, mitochondrial dysfunction, plasticity, and endo/exocytosis.

Neuroinflammation is characterized by the activation of innate immune response due to misfolded/aggregated proteins or systemic infections that trigger microglial and astroglial activation and the consequent release of inflammatory cytokines and chemokines. This response is intended to be beneficial at early stages, promoting aggregates and neuron debris clearance, but if inflammation becomes chronic, it exacerbates neurodegeneration.

These processes are modulated by signaling pathways that, regardless of the underlying core pathophysiological cause, are similarly impaired and associated with converging phenotypes including depression (in early stages of the diseases), motor symptoms, autonomic dysfunction, and dementia.

One of the key kinases involved in neurodegeneration and inflammation is the mechanistic target of rapamycin (mTOR).

This special issue of the International Journal of Molecular Sciences is dedicated to research papers and review articles regarding the involvement of mTOR/Akt signalling in neurodegeneration and the intertwined inflammatory processes that are triggered. We would like to cover mTOR-mediated mechanisms that contribute to synaptic dysfunction, neuron death, circuit impairment, micro- and astrogliosis and neuroinflammation and neurodegeneration.

We encourage authors to submit mTOR-related molecular studies in but not limited to:

1. a) a neurodegenerative context (AD, PD, HD, ALS).
2. b) stroke or traumatic brain injuries.
3. c) pathogenic infections affecting the brain, such as SARS-CoV-2 or HIV.

Prof. Dr. Cristina Malagelada
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• brain disorders
• mTOR
• inflammation
• microglia
• astroglia
• cytokine
• inflammasome
• stroke
• traumatic brain injury
• Parkinson’s disease
• Alzheimer’s disease
• Huntington’s disease
• Amyotrophic Lateral Sclerosis
• SARS-CoV2
• HIV